Weifang Ruze New Material Co., Ltd.

 

Your Aspiration is Our Commitment

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsAntineoplastic Drugs

Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0

Ruze supply good service, thanks.

—— Gaurav

I'm Online Chat Now

Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0

China Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0 supplier
Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0 supplier Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0 supplier

Large Image :  Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0

Product Details:

Place of Origin: Weifang,China
Brand Name: Ruze
Certification: COA MSDS
Model Number: 668270-12-0

Payment & Shipping Terms:

Minimum Order Quantity: Negotiable
Price: Negotiable
Packaging Details: durm
Delivery Time: 5-7 work days
Payment Terms: L/C, T/T, Western Union, MoneyGram
Supply Ability: 1000kg/week
Contact Now
Detailed Product Description
CAS: 668270-12-0 Color: White Powder
Storage: -20°C Purity: 99%min
MF: C25H28N8O2 MW: 472.54

 

Advantage of our API-CAS 668270-12-0  Linagliptin

 

1. High purity

2. Consistent quality for Lorlatinib

3. Competitive price

4. Fast Shipping for Lorlatinib

 

Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0

Product: Linagliptin
CAS: 668270-12-0
Molecular Formula:C25H28N8O2
Purity :99.0%
Specification:Enterprise Standard

Appearance:white crystal powder

 

What's the Linagliptin?

Linagliptin is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes.
Linagliptin was approved by the U.S. Food and Drug Administration (FDA) on 2 May 2011 for treatment of type II diabetes.

 

Test Items Specifications
Appearance White or off white crystalline powder
Identification
IR

The sample spectrum corresponds to that of the

working standard

 

HPLC

The retention time of the major peak in the

chromatogram of the sample corresponds to that exhibited by the working standard

Loss on drying No more than 1.0%
Residue on ignition No more than 0.1%
Heavy Metals No more than 20ppm

 

Related substances

Total impurities no more than 1.5%
  Single impurity no more than 0.5%

 

Residual solvents

Ethyl acetate No more than 0.2%
  Ethanol No more than 0.2%
Purity No less than 98.5%
Conclusion Conforms to the In-house standard.

 

Function:

1. Incretin (Incretin) has the role of intestinal promoting insulin B cells to secrete insulin, mainly including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). DDP-4 is a serine protease located on the cell surface, which is widely found in plasma and in vivo tissues (such as kidney, liver, small intestine villi, endothelial cells, etc.). Rilalitine is a selective DPP-4 inhibitor that inhibits the activity of the enzyme by reversibly binding to DPP-4, delays GLP-1 degradation, enhances GLP-1 activity, and stimulates glucose-dependent Insulin secretion, and reduce circulating levels of glucagon, thereby regulating blood glucose levels in patients with type 2 diabetes.


2. Compared with other DPP-4 inhibitors, the main advantages of liradetine is: with excellent renal safety, and can effectively reduce glycosylated hemoglobin. Lilardine mainly in the form of excretion of fecal excretion, the oral administration, the amount of renal excretion is only 5% of the dose, even if the intravenous administration, and only 30.8% of the excretion by the kidney, so the patient did not need treatment Regularly check the liver, kidney function and dose adjustment, all patients can be a unified fixed dose, easy to prescribe.

 

 

 

 

Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0

Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0

 

Linagliptin Antineoplastic Drugs , Anticancer Agents Cas 668270-12-0

 

 

We have complete experimental facilities. And advanced testing instruments ensure the stability of product quality from all aspects. We have a complete sales service system, the products are exported to countries all over the world, and have won a good international reputation with excellent quality and excellent service.Our business is based on honesty and mutual trust. Sincerely look forward to establishing long-term mutually beneficial and good cooperation with customers all over the world.

 

 

Packaging Detail

0.5kgs/Al-Bottle

1.0kgs/Al- Bottle

2.0kgs/Al- Bottle

5.0 kgs/Al-Bottle

25.0 kgs/drum

or upon customers' request.

Storage Store in a well-closed container away from moisture
Shelf Life 2 years if sealed and store away from direct sun light.
Delivery Detail within 3 days after get the payment

Contact Details
Weifang Ruze New Material Co., Ltd.

Contact Person: Ma

Tel: 86-13583611556

Send your inquiry directly to us (0 / 3000)